According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives. In most cases, it is treatable, yet there are some cases where all known therapies are met with resistance and things take a turn for the worse. However, a new study involving mouse models revealed that a precursor to vitamin K can potentially slow prostate cancer growth.
Groundbreaking Study on Vitamin K and Cancer
researchers in a lab
Credit: Pexels
A recent discovery at Cold Spring Harbor Laboratory potentially offers a novel solution to the prostate cancer issue. Professor Lloyd Trotman and his team have discovered that the pro-oxidant supplement menadione reduces the development of prostate cancer in studies involving mice. Menadione is found in leafy greens and is a precursor to vitamin K. While this study itself is new, it is the result of another study that took place at the beginning of this century.
ADVERTISEMENT
Transforming Yogurt into Creamy Butter
You will no longer throw away watermelon peels: they are worth gold reused like this
Powerful Fig Leaf Tea: A Friend of Diabetics
Creamy Apple and Lotus Biscuit Dessert: A No-Bake Delight
Wow, I couldn’t ask for anything else, mozzarella bread with garlic is so delicious!
The fastest trick to clean stoves and hobs and leave them looking like new
Scared by a spider, she loses control of her car and ends up in the ditch
Placki z dyni na słodko
Biscuits and Gravy with Sausage and Egg Breakfast Casserole
